Patient noncompliance is a costly problem for the healthcare industry, making direct-to-patient marketing initiatives critical. According to the FDA, 30 percent to 50 percent of patients nationwide do not use prescription drugs as directed.
However, findings from a recent study by Health Resource Publishing, based in St. Louis, Mo., indicate that direct-to-patient marketing can make a difference. Findings include:
- Non-compliance dropped 9.9 percent in stores where patients received customized newsletters.
- Non-persistence dropped 11.6 percent Non-persistence is defined as the percent of physician-authorized therapy not purchased by the patient.
Source: Health Resource Publishing